1. which
of the following is a type b (unpredictable) adverse
drug reaction:
a.
side effect
b.
toxic effect
c.
idiosyncrasy
d. physical dependence
|
C
|
2. drugs
producing allergic reactions generally act as:
a.
complete antigens
b.
haptenes
c.
antibodies
d. mediators
|
B
|
3. which
of the following is the only life saving measure in
case of anaphylactic shock:
a.
intravenous hydrocortisone hemisuccinate
b.
intravenous chlorpheniramine maleate
c.
intramuscular adrenaline hydrochloride
d. intravenous glucose-saline
|
C
|
4. intradermal
drug sensitivity tests can detect the presence of following type of
hypersensitivity:
a.
type i (anaphylactic)
b.
type ii (cytolytic)
c.
type iii (retarded)
d. all of the above
|
a
|
the
most vulnerable period of pregnancy for the
causation
of foetal malformations due to drugs is:
a.
18-55 days of gestation
b.
56-84 days of gestation
c.
second trimester
d. 36 weeks onwards
|
A
|
functional
proteins that are target of drug action
i.enzymes
ii.transporters
iii.ion
channels
iv.receptors
correct
a.i,ii,iii
b.ii,iv
c.i,ii
d.i,ii,iii,iv
|
D
|
5. which
of the following drug is a competitive inhibitor of enzyme but non equilibrium type
a.physostigmine
compete with acetycholine for cholinesterase
b.sulfonamide
compete with paba for bacterial folate synthase
c.allopurinol
compete with hypoxanthenes for xanthine oxidase
d.organophosphate
compete with acetylcholine for cholinestrase
|
D
|
6. which
of the following drug is not a non competitive inhibitor of enzyme
a.acetazolamide
inhibit carbonic anhydrase
b.disulfiram
inhibit aldehyde dehydrogenase
c.digoxin
inhibit na k atpase
d
captopril inhibit ace enzyme
|
D
|
7. select
the drug act through ion channel
a.ethosuximide
b.amiloride
c.both
a nd b
d.none
of these
|
C
|
select
the drug act through transporters
i.fluoxetine
ii.phenytoin
iii.furosemide
iv.desipramine
correct
a.i,ii,iii
b.i,iii,iv
c.ii,iii,iv
d.i,ii,iii,iv
|
b
|
select
the wrong statement
a.competitive
antagonist have high affinity and high
intrinsic activity
b.partial
agonist have affinity and sub maximal intrinsic activity
c.inverse
agonist have affinity but intrinsic activity with a minus sign
d.agonist
have both high affinity and maximal
intrinsic
activity
|
A
|
8. select
the partial agonist
a.naloxone
b.pentazocine
c.atropine
d.morphine
|
B
|
9. select
the competitive antagonist
a.propranolol
b.atropine
c.naloxone
d.all
of these
|
D
|
10. select
the following which act through enzyme linked receptors
a.insulin
b.epidermal
growth factor
c.both
of these
d.gaba-a
|
C
|
11. which
of the following is ion channel receptor
i.gaba,glycine
ii.nmda,5-ht3
iii.nicotinic
cholinergic
iv.5-ht1,dopamine
correct
a.i,ii,iii,iv
b.i,ii,iii
c.ii,iii,iv
d.i,ii,iv
|
b
|
12. which
of the following is a g protein coupled receptor, act through ip3 dag pathway
a.muscarinic-1
b.muscarinic-2
c.muscarinic-3
d.all
a,b,c
e.
both a and c
|
e
|
13. histamine
is a g coupled protein receptor,which of the following statement is true
a.h-2
act through adenylyl cyclase pathway by increasing camp
b.h-1
act through ip3 dag pathway
c.
h-2 act through adenylyl cyclase pathway by decreasing camp
d.both
a and b
|
d
|
14. select
the ligand act through ip3 dag pathway(gpcr)
a.5-ht2
b.5-ht1
c.5-ht3
d.all
of these
|
a
|
15. vit-a
and d act through
a.gpcr
b.ion
channel
c.nuclear
receptor
d.enzyme
linked receptor
|
c
|
16. select
the intracellular receptor
a.gpcr
b.ion
channel
c.nuclear
receptor
d.enzyme
linked receptor
|
c
|
17. A
receptor which itself has enzymatic property is:
a.
insulin receptor
b.
progesterone receptor
c.
thyroxine receptor
d. glucagon receptor
|
a
|
18. ‘drug
efficacy’ refers to:
a.
the range of diseases in which the drug is
beneficial
b.
the maximal intensity of response that can
be
produced by the drug
c.
the dose of the drug needed to produce half
maximal
effect
d.
the dose of the drug needed to produce therapeutic
effect
|
b
|
19. which
of the following is always true:
a.
a more potent drug is more efficacious
b.
a more potent drug is safer
c.
a more potent drug is clinically superior
d.
a more potent drug can produce the same
response at lower doses
|
d
|
Monday, 17 July 2017
Target GPAT-2018 General Pharmacology Series- 4
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment